Search hospitals > Florida > West Palm Beach
Palm Beach Research Center
Claim this profileWest Palm Beach, Florida 33409
Global Leader in Lower Back Pain
Global Leader in Osteoarthritis
Conducts research for Back Pain
Conducts research for Migraine
Conducts research for COVID-19
113 reported clinical trials
2 medical researchers
Summary
Palm Beach Research Center is a medical facility located in West Palm Beach, Florida. This center is recognized for care of Lower Back Pain, Osteoarthritis, Back Pain, Migraine, COVID-19 and other specialties. Palm Beach Research Center is involved with conducting 113 clinical trials across 83 conditions. There are 2 research doctors associated with this hospital, such as Mira Baron and Pamela Kane.Top PIs
Mira BaronPalm Beach Research Center3 years of reported clinical research
Studies Obstructive Sleep Apnea
Studies Respiratory Syncytial Virus
17 reported clinical trials
27 drugs studied
Pamela KanePalm Beach Research Center2 years of reported clinical research
Studies Alzheimer's Disease
Studies Migraine
3 reported clinical trials
4 drugs studied
Clinical Trials running at Palm Beach Research Center
Obstructive Sleep Apnea
Obesity
Type 2 Diabetes
Alzheimer's Disease
Sleep Disorders
Diabetes
Sleep Apnea
Menopausal Sleep Disturbances
Retatrutide
for Type 2 Diabetes and Obesity
The purpose of this study is to is to evaluate the efficacy and safety of retatrutide in participants with type 2 diabetes in participants who have obesity or overweight (J1I-MC-GZBK master protocol) including a subset of participants who have obstructive sleep apnea (OSA) (J1I-MC-GSA2). The study will last about 89 weeks and will include up to 24 visits.
Recruiting1 award Phase 37 criteria
AD109
for Obstructive Sleep Apnea
This is a Phase 3 Randomized Double-Blind Placebo-Controlled 1-year Parallel-Arm Study to Compare a Fixed Dose Combination of AD109 to Placebo in Obstructive Sleep Apnea.
Recruiting1 award Phase 35 criteria
IHL-42X
for Obstructive Sleep Apnea
The goal of this randomised, double-blind phase II/III clinical trial is to determine the safety and efficacy of IHL-42X in subjects with obstructive sleep apnoea who are intolerant, non-compliant, or naïve to positive airway pressure. Phase II study will be a 4-week dose-finding study comparing two dose strengths of IHL-42X to placebo. The optimal dose strength will be selected based on comparing the safety and efficacy of the two IHL-42X dose strengths to placebo over a 4-week treatment period. The three treatment groups are; IHL-42X Low dose (2.5mg dronabinol, 125mg acetazolamide), IHL-42X High dose (5mg dronabinol, 250mg acetazolamide) and Placebo. Each treatment group will enrol approximately 40 patients per treatment arm, for a total of approximately 120 patients. The safety and efficacy results of the Phase II study will be used to select the dose strength of IHL-42X and corresponding doses of dronabinol and acetazolamide in Phase III. Phase III study will use the optimal dose strength of IHL-42X identified in Phase II and will be compared to the component active pharmaceutical ingredients at equivalent dose strengths to those found in the IHL-42X optimal dose strength and placebo over 52 weeks. The four treatment groups are; IHL-42X (optimal dose from Phase II), Acetazolamide (equivalent dose strength to that in the IHL-42X optimal dose strength), Dronabinol (equivalent dose strength to that in the IHL-42X optimal dose strength) and placebo. The treatment groups will enrol approximately 165 patients in IHL-42X, approximately 55 patients in dronabinol, approximately 55 in acetazolamide, and approximately 165 in placebo, for a total of approximately 440 patients.
Recruiting0 awards Phase 2 & 32 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Palm Beach Research Center?
Palm Beach Research Center is a medical facility located in West Palm Beach, Florida. This center is recognized for care of Lower Back Pain, Osteoarthritis, Back Pain, Migraine, COVID-19 and other specialties. Palm Beach Research Center is involved with conducting 113 clinical trials across 83 conditions. There are 2 research doctors associated with this hospital, such as Mira Baron and Pamela Kane.